Additionally, serum intact PTH management targets are ≤ 70 pg/mL up to CKD stage 3, ≤ 100 pg/mL for stage 4, and 100–300 pg/mL for stages 5 and 5D. The gene discussed is PTH; the disease is chronic kidney disease.